LoginGet started
Picture of OptimizeRx logo

OPRX — OptimizeRx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for OptimizeRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3.14-2.210.378-11.4-17.6
Depreciation
Non-Cash Items2.183.625.6916.123.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.88-9.69-7.313.96-15.5
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-1.66-6.310.72610.7-7.24
Capital Expenditures-1.59-0.125-0.464-0.243-0.871
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items-8.990-0.022-57.9-24.5
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities-10.6-0.125-0.486-58.2-25.3
Financing Cash Flow Items—-4.39-1.610—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities22.2-1.973.9-1928.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9.94-8.3474.2-66.5-4.36